- Home
- MOND vs RGLS Comparison
MOND vs RGLS Comparison
Compare MOND & RGLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOND
- RGLS
- Stock Information
- Founded
- MOND 2011
- RGLS 2007
- Country
- MOND United States
- RGLS United States
- Employees
- MOND N/A
- RGLS N/A
- Industry
- MOND Transportation Services
- RGLS Biotechnology: Pharmaceutical Preparations
- Sector
- MOND Consumer Discretionary
- RGLS Health Care
- Exchange
- MOND Nasdaq
- RGLS Nasdaq
- Market Cap
- MOND 87.6M
- RGLS 102.1M
- IPO Year
- MOND N/A
- RGLS 2012
- Fundamental
- Price
- MOND $0.98
- RGLS $1.40
- Analyst Decision
- MOND Buy
- RGLS Strong Buy
- Analyst Count
- MOND 4
- RGLS 6
- Target Price
- MOND $3.63
- RGLS $10.33
- AVG Volume (30 Days)
- MOND 146.4K
- RGLS 493.3K
- Earning Date
- MOND 11-18-2024
- RGLS 11-07-2024
- Dividend Yield
- MOND N/A
- RGLS N/A
- EPS Growth
- MOND N/A
- RGLS N/A
- EPS
- MOND N/A
- RGLS N/A
- Revenue
- MOND $232,972,000.00
- RGLS N/A
- Revenue This Year
- MOND $11.81
- RGLS N/A
- Revenue Next Year
- MOND $15.08
- RGLS N/A
- P/E Ratio
- MOND N/A
- RGLS N/A
- Revenue Growth
- MOND 28.39
- RGLS N/A
- 52 Week Low
- MOND $0.68
- RGLS $1.08
- 52 Week High
- MOND $3.37
- RGLS $3.79
- Technical
- Relative Strength Index (RSI)
- MOND 35.29
- RGLS 41.95
- Support Level
- MOND $0.68
- RGLS $1.36
- Resistance Level
- MOND $1.40
- RGLS $1.65
- Average True Range (ATR)
- MOND 0.17
- RGLS 0.10
- MACD
- MOND -0.04
- RGLS -0.01
- Stochastic Oscillator
- MOND 33.62
- RGLS 28.57
About MOND Mondee Holdings Inc.
Mondee Holdings Inc is a travel technology company & marketplace with a portfolio of leisure & corporate travel sectors. The company provides AI platforms, technologies, operating systems, & services that enable travel transactions to serve travelers directly or through travel affiliates. The company has two segments Travel Marketplace & SAAS Platform. The Travel Marketplace segment consists of selling airline tickets through the proprietary platform. The SAAS Platform segment offers corporate travel cost savings solutions through its technology platform. The majority is from the Travel Marketplace segment. Geographically, the key revenue is from the United States.
About RGLS Regulus Therapeutics Inc.
Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases. The product candidate of the company is RGLS8429, an anti-miR next-generation oligonucleotide targeting miR-17 for the treatment of autosomal dominant polycystic kidney disease (ADPKD), and is in Phase 1b clinical development.